相关实验视频
Updated: Sep 19, 2025

07:33
A Mouse Model of Intestinal Partial Obstruction
Published on: March 5, 2018
21.5K
莫奇诱导的十二指肠阻塞和:一个病例报告
Shogo Shirota1,2, Nobuyasu Hirai3, Hajime Hanno3
1General Medicine, Osaka Medical and Pharmaceutical University Hospital, Takatsuki, JPN.
Cureus
|June 17, 2025
概括
粘的米糕莫奇 (Mochi) 可能导致十二指肠阻塞和,特别是在糖尿病患者中. 早期CT和内镜评估是诊断和治疗这种罕见的胃肠道并发症的关键.
科学领域:
- 胃肠病学 胃肠病学
- 消化系统疾病 消化系统疾病
- 医学案例报告 病例报告
背景情况:
- 莫奇 (米糕) 以其粘合性而闻名,可能导致胃肠道阻塞和的风险.
- 虽然小肠和胃部的参与被记录在案,但由于莫奇的消费而导致的十二指肠并发症很少被报告.
研究的目的:
- 报告一个罕见的十二指甲管阻塞和由摩奇冲击引起的的病例.
- 讨论可能导致的因素,如糖尿病和胃肠机动性受损,在mochi诱导的十二指肠并发症.
- 强调在无法解释的上部胃肠道阻塞的情况下,考虑饮食史的诊断重要性.
主要方法:
- 一个64岁的男性患者的病例报告,有糖尿病病史,出现腹痛和吐的症状.
- 使用腹部计算机断层扫描 (CT) 进行诊断成像,以识别胃和十二指肠中的高密度物质.
- 内镜检查可视化和确认十二指肠和胃以及莫奇冲击.
主要成果:
- 计算机断层扫描揭示了胃和十二指肠内的多种高密度材料.
- 内镜检查证实了十二指肠和胃的多种,显著的莫奇冲击阻碍了十二指肠.
- 十二指甲膜阻塞通过对受影响的肌肉的内镜碎片成功管理.
结论:
- 摩奇冲击可以导致严重的十二指甲膜阻塞和,尽管很少发生.
- 在患有糖尿病的患者中,胃肠道运动能力受损可能会增加因摩奇诱导的十二指肠并发症的风险.
- 胃或十二指肠中高密度物质的放射性发现需要详细的饮食史,特别是关于莫奇的消费,以进行准确的诊断和管理.
相关概念视频
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
212
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
212
Peptic Ulcer Disease II: Pathophysiology
907
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
907
Esophageal Strictures-II: Clinical Features and Management
169
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
169
Peptic Ulcer Disease IV: Management
151
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
151
Peptic Ulcer Disease I: Introduction
305
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
305
Esophageal Perforation-II: Clinical Manifestations and Management
154
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
154

